Varex Imaging (FRA:VI4) Current Deferred Revenue: €7.5 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VI4 Varex Imaging Corp FRA:VI4
70 GF Score
Price €15.90
GF Value €11.05
! 6 Warning Signs
View Full Analysis

What is Varex Imaging Current Deferred Revenue?

Varex Imaging FRA:VI4 +1.92% 70 Current Deferred Revenue is €7.5 Mil as of Jun. 2026. GuruFocus rates FRA:VI4 with a GF Score™ of 70/100 and a GF Value™ of €11.05. The stock has 6 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Varex Imaging's current deferred revenue for the quarter that ended in Jun. 2026 was €7.5 Mil.

Varex Imaging Current Deferred Revenue Related Terms

Varex Imaging Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Varex Imaging's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Varex Imaging Current Deferred Revenue Chart

Varex Imaging Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.74 7.47 9.56 7.12 11.08

Varex Imaging Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.66 11.08 10.59 12.54 7.47
FRA:VI4
70GF Score
Varex Imaging Corp FRA:VI4
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of €7.5 Mil mean?
Varex Imaging (FRA:VI4) has a Current Deferred Revenue of €7.5 Mil as of Jun. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Varex Imaging and its competitors.
Is Varex Imaging's Current Deferred Revenue too high?
Varex Imaging's current Current Deferred Revenue is €7.5 Mil. Overall, Varex Imaging has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Varex Imaging's Current Deferred Revenue compare to OFIX and VMD?
Varex Imaging's Current Deferred Revenue of €7.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Medical Devices & Instruments company?
A good Current Deferred Revenue depends on the Medical Devices & Instruments industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Varex Imaging and its competitors. Varex Imaging's current Current Deferred Revenue is €7.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Varex Imaging stock overvalued right now?
Varex Imaging (FRA:VI4) has a current Current Deferred Revenue of €7.5 Mil. The stock's GF Value™ is €11.05, compared to a current price of €15.90 — trading 43.9% above its estimated fair value. The current Current Deferred Revenue is €7.5 Mil. Varex Imaging's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Varex Imaging (FRA:VI4), the current Current Deferred Revenue is €7.5 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Varex Imaging (FRA:VI4) Overvalued in 2026?

Based on GuruFocus' analysis, Varex Imaging stock appears to be overvalued. The current stock price of €15.90 is trading 43.9% above its estimated GF Value™ of €11.05.

Key valuation signals for FRA:VI4:

  • Current Deferred Revenue: €7.5 Mil
  • GF Value™: €11.05 vs. price of €15.90 (43.9% above fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the FRA:VI4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Varex Imaging Business Description

Other Exchanges VREX:USA
Address 1678 S. Pioneer Road, Salt Lake City, UT, USA, 84104
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
70GF Score

Get the complete analysis for FRA:VI4

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.90
Price
€11.05
GF Value